News and Trends 26 Mar 2015
Apceth Initiates Phase II for its pioneering Engineered Cell Therapy to treat Gastrointestinal Cancer
After successfully complete phase I clinical study, apceth initiates the Phase II of world’s first genetically-engineered cell therapy. The ongoing monocentric Phase I/II clinical trial TREAT-ME 1 with the engineered cell therapeutic product Agenmestencel-T, will take place at the Klinikum Grosshadern in Munich. This is the first time that a genetically engineered Mesenchymal Stem Cell […]